Krystal Biotech KRYS
NASDAQ KRYS
$334.04 -1.02 (-0.30%)
As of: Sep 30, 2026 · 2:13 PM EDT

Krystal Biotech, Inc. (KRYS) Asset Utilization Ratio (2023 - 2026)

Updated

Krystal Biotech's Asset Utilization Ratio came in at 0.30 for Q2 2026, down 6.3% from 0.32 a year earlier and down 0.5% from the prior quarter.

Analysis

Krystal Biotech, Inc. (KRYS) Asset Utilization Ratio (2023 - 2026) Analysis & Trends

For FY2025, Krystal Biotech's Asset Utilization Ratio was 0.33, up 5.1% from FY2024.

  • Going back by year, Asset Utilization Ratio was 0.31 in FY2024 (+320.9%) and 0.07 in FY2023.
  • The five-year range for quarterly Asset Utilization Ratio is 0.01 (Q3 2023) to 0.32 (Q2 2025).
  • Year-over-year, Asset Utilization Ratio increased in five of the last seven quarters, with growth averaging 88.4%.
  • Business Quant data shows KRYS's Asset Utilization Ratio at 0.31 (Q1 2026), 0.30 (Q4 2025) and 0.31 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.30
Mar 31, 2026 0.31
Dec 31, 2025 0.30
Sep 30, 2025 0.31
Jun 30, 2025 0.32
Mar 31, 2025 0.31
Dec 31, 2024 0.29
Sep 30, 2024 0.25
Jun 30, 2024 0.19
Mar 31, 2024 0.11
Dec 31, 2023 0.06
Sep 30, 2023 0.01
API Access

Krystal Biotech, Inc. Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=KRYS&period=max&api_key=YOUR_API_KEY